Ligne de temps
Thomas Moreau
Post-doctorant(e)
17 oct. 2025
publication
IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodies.
Lire plus14 sept. 2025
publication
Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositis.
Lire plus01 août 2023
02 juil. 2020